Back to Search Results
Study Complete
Sponsor ID
20080234

Study to Evaluate the Prospective Payment SystemSTEPPS™

Sponsor ID
20080234
Clinicaltrials.gov ID
NCT01717989
EUCTIS ID
N/A
EudraCT ID
N/A
Contact Us

Study Details

To describe trends in treatment patterns of Small Dialysis Organizations (SDOs) prior to and during the implementation of the Centers for Medicare and Medicaid Services’ (CMS’) policy [End Stage Renal Disease (ESRD) Prospective Payment System (PPS)] to bundle reimbursement for all dialysis services. Specifically, to describe CMS ESRD PPS quality performance measures for dialysis centers over time.

Additional Study Details

Phase
N/A
Product
epoetin alfa
Type
Observational
Masking
N/A
Enrollment
2248
Additional Study Details

Protocol Summary

Primary Outcome Measures

Proportion of patients within each facility meeting each of the Centers for Medicare and Medicaid policy for End Stage Renal Disease Prospective Payment System quality metrics over time

Timeframe: Up to 54 months

Secondary Outcome Measures

Practice of Site Treatment Patterns

Timeframe: Up to 54 months

Locations

Location
Status
Contact Us
Location
Research Site
East Point, GA, United States, 30344
Status
Completed
Location
Research Site
Pembroke Pines, FL, United States, 33028
Status
Completed
Location
Research Site
Arlington, TX, United States, 76015
Status
Recruiting
Location
Research Site
Azusa, CA, United States, 91702
Status
Completed
Location
Research Site
Bakersfield, CA, United States, 93309
Status
Completed
Location
Research Site
Blairsville, GA, United States, 30512
Status
Completed
Showing {first} - {last} of {total} Results
Study Info
Age
N/A
Condition
  • Kidney Disease
    • Sex
    All
    Trial Dates
    Jun 2010 - Sep 2012
    Inclusion and Exclusion Criteria
    Patient Inclusion Criteria: - Adults ≥ 18 years of age who have given written informed consent - Documented physician diagnosis of ESRD requiring dialysis and receiving care at a participating dialysis center - Undergoing dialysis on the dialysis schedule assigned to the site Patient Exclusion Criteria: - Patients will be ineligible for the study if they do not consent to have their data collected for research purposes.